• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Commentary: Adenosine A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism.

作者信息

de Souza Marina F, Bispo José M M, Leal Pollyana C, de Gois Auderlan M, Dos Santos José R

机构信息

Department of Physiology, Federal University of SergipeSão Cristovão, Brazil.

Behavioral and Evolutionary Neurobiology Laboratory, Department of Biosciences, Federal University of SergipeItabaiana, Brazil.

出版信息

Front Behav Neurosci. 2017 May 19;11:93. doi: 10.3389/fnbeh.2017.00093. eCollection 2017.

DOI:10.3389/fnbeh.2017.00093
PMID:28579949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5437116/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/571b/5437116/41beb0616c48/fnbeh-11-00093-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/571b/5437116/41beb0616c48/fnbeh-11-00093-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/571b/5437116/41beb0616c48/fnbeh-11-00093-g0001.jpg

相似文献

1
Commentary: Adenosine A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism.评论：腺苷A受体阻断可预防帕金森病大鼠模型中鱼藤酮诱导的运动障碍。
Front Behav Neurosci. 2017 May 19;11:93. doi: 10.3389/fnbeh.2017.00093. eCollection 2017.
2
Adenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism.腺苷A2A受体阻断可预防帕金森病大鼠模型中鱼藤酮诱导的运动功能障碍。
Front Behav Neurosci. 2016 Feb 29;10:35. doi: 10.3389/fnbeh.2016.00035. eCollection 2016.
3
Selective A receptors blockade reduces degeneration of substantia nigra dopamine neurons in a rotenone-induced rat model of Parkinson's disease: A histological study.选择性 A 受体阻断可减轻鱼藤酮诱导的帕金森病大鼠模型中黑质多巴胺能神经元的退变：一项组织学研究。
Neurosci Lett. 2017 Mar 16;643:89-96. doi: 10.1016/j.neulet.2017.02.036. Epub 2017 Feb 15.
4
Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.腺苷A2A拮抗剂CSC在帕金森病6-OHDA大鼠模型中诱导的神经保护作用：对纹状体输出通路活性的影响
Exp Brain Res. 2005 Sep;165(3):362-74. doi: 10.1007/s00221-005-2302-1. Epub 2005 Jun 21.
5
Dose-dependent neuroprotective effect of caffeine on a rotenone-induced rat model of parkinsonism: A histological study.咖啡因对鱼藤酮诱导的帕金森病大鼠模型的剂量依赖性神经保护作用：一项组织学研究。
Neurosci Lett. 2016 Jun 3;623:63-70. doi: 10.1016/j.neulet.2016.04.057. Epub 2016 Apr 27.
6
Potential therapeutic effects of antagonizing adenosine A receptor, curcumin and niacin in rotenone-induced Parkinson's disease mice model.抑制腺苷 A 受体、姜黄素和烟酸在鱼藤酮诱导的帕金森病小鼠模型中的潜在治疗作用。
Mol Cell Biochem. 2020 Feb;465(1-2):89-102. doi: 10.1007/s11010-019-03670-0. Epub 2019 Dec 9.
7
Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.腺苷A1 - A2A受体异聚体：大脑中咖啡因的新靶点。
Front Biosci. 2008 Jan 1;13:2391-9. doi: 10.2741/2852.
8
Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone.咖啡因对鱼藤酮诱导的帕金森病大鼠模型的神经保护及治疗作用
J Diet Suppl. 2017 Sep 3;14(5):553-572. doi: 10.1080/19390211.2016.1275916. Epub 2017 Feb 13.
9
Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure.腺苷A1和A2A受体对伏隔核壳部谷氨酸和多巴胺释放的相反调节作用。长期咖啡因暴露的影响。
J Neurochem. 2004 Mar;88(5):1151-8. doi: 10.1046/j.1471-4159.2003.02245.x.
10
Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.咖啡因在帕金森病MPTP模型中的神经保护作用及其对腺苷A2A受体的依赖性。
Neuroscience. 2016 May 13;322:129-37. doi: 10.1016/j.neuroscience.2016.02.035. Epub 2016 Feb 22.

引用本文的文献

1
Quantitative Structure-Neurotoxicity Assessment and In Vitro Evaluation of Neuroprotective and MAO-B Inhibitory Activities of Series '-substituted 3-(1,3,7-trimethyl-xanthin-8-ylthio)propanehydrazides.一系列 '-取代 3-(1,3,7-三甲基黄嘌呤-8-基硫代)丙酰肼的定量结构-神经毒性评估和体外神经保护及 MAO-B 抑制活性评价。
Molecules. 2022 Aug 20;27(16):5321. doi: 10.3390/molecules27165321.
2
The Pharmacological Potential of Adenosine A Receptor Antagonists for Treating Parkinson's Disease.腺苷 A 受体拮抗剂治疗帕金森病的药理学潜力。
Molecules. 2022 Apr 6;27(7):2366. doi: 10.3390/molecules27072366.

本文引用的文献

1
Potential Role of Caffeine in the Treatment of Parkinson's Disease.咖啡因在帕金森病治疗中的潜在作用。
Open Neurol J. 2016 Jul 26;10:42-58. doi: 10.2174/1874205X01610010042. eCollection 2016.
2
Dose-dependent neuroprotective effect of caffeine on a rotenone-induced rat model of parkinsonism: A histological study.咖啡因对鱼藤酮诱导的帕金森病大鼠模型的剂量依赖性神经保护作用：一项组织学研究。
Neurosci Lett. 2016 Jun 3;623:63-70. doi: 10.1016/j.neulet.2016.04.057. Epub 2016 Apr 27.
3
Adenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism.
腺苷A2A受体阻断可预防帕金森病大鼠模型中鱼藤酮诱导的运动功能障碍。
Front Behav Neurosci. 2016 Feb 29;10:35. doi: 10.3389/fnbeh.2016.00035. eCollection 2016.
4
Alterations in behavioral responses to dopamine agonists in olfactory bulbectomized mice: relationship to changes in the striatal dopaminergic system.嗅球切除小鼠对多巴胺激动剂行为反应的改变：与纹状体多巴胺能系统变化的关系。
Psychopharmacology (Berl). 2016 Apr;233(7):1311-22. doi: 10.1007/s00213-016-4224-y. Epub 2016 Feb 9.
5
Purinergic signaling in Parkinson's disease. Relevance for treatment.帕金森病中的嘌呤能信号传导。治疗相关性。
Neuropharmacology. 2016 May;104:161-8. doi: 10.1016/j.neuropharm.2015.07.024. Epub 2015 Jul 23.
6
An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions.帕金森病鱼藤酮模型的最新进展：其再现临床疾病特征及模拟基因-环境相互作用的能力。
Neurotoxicology. 2015 Jan;46:101-16. doi: 10.1016/j.neuro.2014.12.002. Epub 2014 Dec 13.
7
Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant.两种用于治疗帕金森病的新型腺苷受体拮抗剂：异他茶碱与托扎腺苷
Expert Opin Pharmacother. 2014 Jun;15(8):1097-107. doi: 10.1517/14656566.2014.903924. Epub 2014 Mar 27.
8
Caffeine for treatment of Parkinson disease: a randomized controlled trial.咖啡因治疗帕金森病：一项随机对照试验。
Neurology. 2012 Aug 14;79(7):651-8. doi: 10.1212/WNL.0b013e318263570d. Epub 2012 Aug 1.
9
Toxin models of mitochondrial dysfunction in Parkinson's disease.帕金森病中线粒体功能障碍的毒素模型。
Antioxid Redox Signal. 2012 May 1;16(9):920-34. doi: 10.1089/ars.2011.4033. Epub 2011 Jul 12.
10
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.帕金森病动物模型：新型治疗方法的来源和疾病病因的线索。
Br J Pharmacol. 2011 Oct;164(4):1357-91. doi: 10.1111/j.1476-5381.2011.01426.x.